ChasmanthinCAS# 20379-19-5 |
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
| Cas No. | 20379-19-5 | SDF | Download SDF |
| PubChem ID | 442012 | Appearance | Powder |
| Formula | C20H22O7 | M.Wt | 374.4 |
| Type of Compound | Diterpenoids | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | (1S,2S,3S,5R,8R,11R,12S,13S,15S)-5-(furan-3-yl)-12-hydroxy-3,11-dimethyl-6,14,16-trioxapentacyclo[10.3.2.02,11.03,8.013,15]heptadecane-7,17-dione | ||
| SMILES | CC12CCC3C(=O)OC(CC3(C1C4C5C(C2(C(=O)O4)O)O5)C)C6=COC=C6 | ||
| Standard InChIKey | TXOMRNMZLZXJQP-OQDMGONLSA-N | ||
| Standard InChI | InChI=1S/C20H22O7/c1-18-7-11(9-4-6-24-8-9)25-16(21)10(18)3-5-19(2)14(18)12-13-15(26-13)20(19,23)17(22)27-12/h4,6,8,10-15,23H,3,5,7H2,1-2H3/t10-,11+,12+,13-,14-,15-,18+,19+,20-/m0/s1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
Chasmanthin Dilution Calculator
Chasmanthin Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 2.6709 mL | 13.3547 mL | 26.7094 mL | 53.4188 mL | 66.7735 mL |
| 5 mM | 0.5342 mL | 2.6709 mL | 5.3419 mL | 10.6838 mL | 13.3547 mL |
| 10 mM | 0.2671 mL | 1.3355 mL | 2.6709 mL | 5.3419 mL | 6.6774 mL |
| 50 mM | 0.0534 mL | 0.2671 mL | 0.5342 mL | 1.0684 mL | 1.3355 mL |
| 100 mM | 0.0267 mL | 0.1335 mL | 0.2671 mL | 0.5342 mL | 0.6677 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Sanggenon B
Catalog No.:BCX0252
CAS No.:81381-67-1
- Kaempferol 3-O-(2''-O-glucosyl)rutinoside
Catalog No.:BCX0251
CAS No.:55696-58-7
- Dehydrozingerone
Catalog No.:BCX0250
CAS No.:1080-12-2
- (2S,3S)-Pteroside C
Catalog No.:BCX0249
CAS No.:98855-62-0
- (2R,3S)-Pteroside C
Catalog No.:BCX0248
CAS No.:68399-16-6
- Pterosin L 2'-O-glucoside
Catalog No.:BCX0247
CAS No.:61102-11-2
- Pyridylpaeoniflorin
Catalog No.:BCX0246
CAS No.:1427054-19-0
- Malaysianol D
Catalog No.:BCX0245
CAS No.:1646330-59-7
- Bisacurone A
Catalog No.:BCX0244
CAS No.:127214-84-0
- ar-Turmerol
Catalog No.:BCX0243
CAS No.:1178899-16-5
- (S,E)-2-Methyl-6-(p-tolyl)hept-3-en-2-ol
Catalog No.:BCX0242
CAS No.:18383-55-6
- Creticoside A
Catalog No.:BCX0241
CAS No.:34336-00-0
- Dulcisxanthone B
Catalog No.:BCX0254
CAS No.:869669-62-5
- (E)-4-(4-Hydroxyphenyl)but-3-en-2-one
Catalog No.:BCX0255
CAS No.:22214-30-8
- (E)-α-Atlantone
Catalog No.:BCX0256
CAS No.:26294-59-7
- Arucadiol
Catalog No.:BCX0257
CAS No.:105037-85-2
- Suffruticosol B
Catalog No.:BCX0258
CAS No.:220936-87-8
- Sibiriquinone B
Catalog No.:BCX0259
CAS No.:723300-09-2
- Sanggenon O
Catalog No.:BCX0260
CAS No.:101664-32-8
- (2S,3S)-Pterosin S 14-O-glucoside
Catalog No.:BCX0261
CAS No.:62043-50-9
- Pruniflorone R
Catalog No.:BCX0262
CAS No.:1238102-65-2
- Assiguxanthone B
Catalog No.:BCX0263
CAS No.:197447-29-3
- N-(3-(4-Fluorophenyl)propyl)-7-hydroxycoumarin-3-carboxamide
Catalog No.:BCX0264
CAS No.:2136579-33-2
- Suffruticosol D
Catalog No.:BCX0265
CAS No.:1261292-11-8
Effect of temperature on hepatitis a virus and exploration of binding mode mechanism of phytochemicals from tinospora cordifolia: an insight into molecular docking, MM/GBSA, and molecular dynamics simulation study.[Pubmed:36995189]
J Biomol Struct Dyn. 2024 Jan-Feb;42(2):598-614.
The hepatitis A virus (HAV), which causes hepatitis A, is a contagious liver ailment. The infections are not specifically treated by any medications. Therefore, the development of less harmful, more effective and cost-effective antiviral agents are necessary. The present work highlighted the in-silico activity of phytocompounds from tinospora cordifolia against HAV. The binding interaction of HAV with the phytocompounds was analyzed through molecular docking. Molecular docking revealed that Chasmanthin, malabarolide, menispermacide, tinosporaside, and tinosporinone compounds bind with HAV more efficiently than other compounds. Further evaluation using 100 ns molecular dynamics simulation, MM/GBSA and free energy landscape indicated that all phytocompounds studied here were found to be most promising drug candidate against hepatitis A virus. Our computational study will encourage promoting in further investigation for in vitro and in vivo clinical trials.Communicated by Ramaswamy H. Sarma.
Antihypertensive activity of phytocompounds from selected medicinal plants via inhibition of angiotensin-converting enzyme (ACE) protein: an in-silico approach.[Pubmed:34825625]
Nat Prod Res. 2022 Sep;36(17):4532-4535.
Hypertension has been a significant cause of death due to elevated blood pressure worldwide. The results of molecular docking showed out of selected 40 compounds, Chasmanthin (-11.05 kcal/mol), and palmarin (-11.22 kcal/mol) showed strong binding with angiotensin-converting enzyme (ACE) target. The inhibitory action of the selected phytocompounds for ACE protein was also validated by comparing it with the reference drugs, lisinopril (-9.42 kcal/mol), and enalapril (-5.07 kcal/mol). MD simulations study of 100 ns also demonstrated stability of Chasmanthin, and palmarin within the active sites of ACE protein. Molecular mechanics generalised born surface area (MMGBSA) analysis of MD trajectories exhibited significant binding of palmarin with ACE (dG Bind= -38.65 +/- 2.59 kcal/mol) and Chasmanthin (dG Bind= -37.64 +/- 2.67 kcal/mol). Drug likeness and pharmacokinetics properties of palmarin and Chasmanthin was also found to be permissible, thereby suggesting the use of Chasmanthin and palmarin as a novel target inhibitor against ACE protein to combat hypertension.
Furanoditerpenes of Fibraurea chloroleuca.[Pubmed:17262463]
Planta Med. 1989 Oct;55(5):477-8.
Fibraurin, Chasmanthin, and palmarin were isolated from the stems of FIBRAUREA CHLOROLEUCA, Fam. Menispermaceae. The structure of the minor constituent, palmarin, was determined by X-ray crystallographic analysis.
